Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Hls Therapeutics Inc (HLS.TO)

Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Stocks in play: HLS Therapeutics Inc. Baystreet - Tue Apr 14, 8:38AM CDT

Announces that CEO Craig Millian will present at the 2026 Bloom Burton & Co. Healthcare Investor Conference, ...

HLS.TO : 4.60 (-1.08%)
HLS Therapeutics to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference PR Newswire - Tue Apr 14, 6:00AM CDT

TORONTO , April 14, 2026 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and...

HLS.TO : 4.60 (-1.08%)
Stocks in play: HLS Therapeutics Inc. Baystreet - Thu Mar 12, 8:55AM CDT

Announces its financial results for the three and 12 months ended December 31, 2025. All amounts are ...

HLS.TO : 4.60 (-1.08%)
HLS Therapeutics to Host Fiscal 2025 Financial Results Conference Call PR Newswire - Thu Feb 26, 6:00AM CST

TORONTO , Feb. 26, 2026 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release financial results for the three and twelve months ended December 31, 2025,...

HLS.TO : 4.60 (-1.08%)
HLS Therapeutics Announces Health Canada Approval of NILEMDO® for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease PR Newswire - Tue Nov 18, 2025

TORONTO , Nov. 18, 2025 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric disorders and...

ESPR : 1.8800 (-1.57%)
HLS.TO : 4.60 (-1.08%)
Esperion Partner HLS Therapeutics Announces Approval of NILEMDO® for the Reduction of LDL-Cholesterol in Canadians at Risk of Cardiovascular Disease GlobeNewswire - Tue Nov 18, 2025

ANN ARBOR, Mich., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that HLS Therapeutics Inc. (TSX: HLS), the Company’s partner in Canada for the development and commercialization...

ESPR : 1.8800 (-1.57%)
HLS.TO : 4.60 (-1.08%)
Stocks in play: HLS Therapeutics Inc. Baystreet - Thu Oct 30, 2025

Will release financial results for the three and nine months ended September 30, 2025, on Thursday, ...

HLS.TO : 4.60 (-1.08%)
HLS Therapeutics and Amarin Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress PR Newswire - Tue Oct 14, 2025

TORONTO , Oct. 14, 2025 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric disorders and...

HLS.TO : 4.60 (-1.08%)
HLS Therapeutics Announces New Credit Agreement Newswire.ca - Wed Aug 20, 2025

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric...

JPM : 309.43 (-0.65%)
HLS.TO : 4.60 (-1.08%)
HLS Therapeutics Announces New Credit Agreement PR Newswire - Wed Aug 20, 2025

TORONTO , Aug. 20, 2025 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric...

HLS.TO : 4.60 (-1.08%)

Barchart Exclusives

Bloom Energy Just Hit an All-Time High. Should You Chase the Rally Here? Barchart - 2 minutes ago
Bloom Energy stock rallies on blockbuster Q1 earnings and raised future guidance. Roth MKM analysts increased their price target on BE shares after the quarterly print. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.